{"id":2565,"date":"2018-11-13T14:20:25","date_gmt":"2018-11-13T14:20:25","guid":{"rendered":"https:\/\/www.mybiosource.com\/learn\/?p=2565"},"modified":"2023-03-13T09:58:50","modified_gmt":"2023-03-13T09:58:50","slug":"influenza-series-recommendations-and-actions-initiated-by-who","status":"publish","type":"post","link":"https:\/\/www.mybiosource.com\/learn\/influenza-series-recommendations-and-actions-initiated-by-who\/","title":{"rendered":"Influenza Series: Recommendations and Actions Initiated by WHO"},"content":{"rendered":"\n\n\n
\n

Table of Contents<\/u><\/strong><\/h3>\n

1. Introduction<\/strong><\/a>
\n2. The global influenza surveillance system<\/strong><\/a>
\n3. The need for modifying the vaccine composition<\/strong><\/a>
\n4. The role of WHO Collaborating Centers and Essential Regulatory Laboratories<\/strong><\/a>
\n5. Guidelines for Clinical Management of Influenza Viruses <\/strong><\/a>
\n6. Influenza Vaccine in Tropics and Subtropics <\/strong><\/a>
\n7. WHO Strategic Action Plan for Pandemic Influenza <\/strong><\/a>
\n\u2022 Importance of Preparing for Pandemic Outbreaks
\n\u2022 New Strategy for Greater Global Preparedness
\n\u2022 Global Influenza Surveillance and Response System (GISRS) and the Pandemic Influenza Preparedness Framework<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

For decades, WHO has continued the surveillance of influenza<\/span> viruses across the globe involving several generations of world-renowned influenza scientists to where it is currently. Yet, influenza continues to remain a threat to humans killing around 650,000 every year.<\/p>\n

The global influenza surveillance system monitors the changes of the influenza viruses with a combined effort to develop effective seasonal influenza vaccine and powerful antiviral drugs. As the influenza virus continues to change, therefore the composition of the vaccine also requires to be modified to match the circulating influenza viruses of the season.<\/p>\n

For the selection of vaccine viruses, WHO organizes twice a year consultations with experts from WHO Collaborating Centers (CCs), Essential Regulatory Laboratories (ERLs) along with other partners to review the information gathered by WHO Global Influenza Surveillance and Response System (GISRS) to make the recommendations on influenza vaccine composition for the next influenza seasons. \u201cWhat\u2019s unique about influenza is it is constantly changing. So for seasonal viruses, these viruses continue to evolve and change and escape the ability of existing vaccines to protect the population,\u201d said Dr Jacqueline Katz, Director of the WHO Collaborating Centre for the Surveillance, Epidemiology<\/span> and Control of Influenza, Atlanta, USA. \u201cWe\u2019re really concerned about being ahead of the game for detecting a virus that could cause the next global pandemic.\u201d<\/em><\/p>\n

In order to reduce the rate of mortality associated with influenza, WHO recommends appropriate measures for the prevention, the treatment of the infection and also providing a strategic action plan for pandemic influenza. Here we discuss the WHO recommendations of antiviral<\/span> treatment, recommended compositions for the influenza vaccines for the northern hemisphere, southern hemisphere, the tropics and the subtropics for the current influenza season. \"\" <\/p>\n

Guidance on Clinical Management of Influenza <\/strong> WHO is currently working on developing a standard guideline for the management of influenza infection which will be applicable to all groups of people internationally. However, WHO guidelines for Pharmacological Management of Influenza viruses were revised in 2010 which recommends;<\/p>\n